AllianceBernstein
CGEM icon

AllianceBernstein’s Cullinan Oncology CGEM Stock Holding History

AllianceBernstein’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
75,250
+27,620
+58% +$410K ﹤0.01% 2356
2026
Q1 		$493K Hold
47,630
– – ﹤0.01% 2641
2025
Q4 		$493K Hold
47,630
– – ﹤0.01% 2665
2025
Q3 		$282K Hold
47,630
– – ﹤0.01% 2966
2025
Q2 		$359K Sell
47,630
-1,675,371
-97% -$13.5M ﹤0.01% 2826
2025
Q1 		$13M Sell
1,723,001
-288,524
-14% -$2.77M ﹤0.01% 1036
2024
Q4 		$24.5M Buy
2,011,525
+157,115
+8% +$2.26M 0.01% 839
2024
Q3 		$31M Buy
1,854,410
+125,865
+7% +$2.23M 0.01% 759
2024
Q2 		$30.1M Buy
1,728,545
+1,695,345
+5,106% +$36.1M 0.01% 755
2024
Q1 		$566K Sell
33,200
-10,180
-23% -$157K ﹤0.01% 2531
2023
Q4 		$442K Sell
43,380
-360
-0.8% -$3.19K ﹤0.01% 2668
2023
Q3 		$396K Hold
43,740
– – ﹤0.01% 2691
2023
Q2 		$471K Buy
43,740
+11,040
+34% +$117K ﹤0.01% 2672
2023
Q1 		$335K Buy
32,700
+4,500
+16% +$49.6K ﹤0.01% 2734
2022
Q4 		$298K Buy
28,200
+1,500
+6% +$18.2K ﹤0.01% 2877
2022
Q3 		$342K Buy
26,700
+2,400
+10% +$32.3K ﹤0.01% 2810
2022
Q2 		$312K Buy
24,300
+10,200
+72% +$116K ﹤0.01% 2864
2022
Q1 		$148K Sell
14,100
-1,800
-11% -$24.3K ﹤0.01% 3055
2021
Q4 		$245K Buy
15,900
+2,100
+15% +$41.9K ﹤0.01% 3003
2021
Q3 		$311K Hold
13,800
– – ﹤0.01% 2940
2021
Q2 		$355K Buy
+13,800
New +$424K ﹤0.01% 2962

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

AllianceBernstein's CGEM Position: Q2 2026 in Review

AllianceBernstein increased its Cullinan Oncology (CGEM) stake by 58% in Q2 2026, buying an estimated $410K and bringing the position to 75,250 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2356.

AllianceBernstein first reported a position in CGEM in Q2 2021 and has held it in 21 quarters since. The position peaked at $31M in Q3 2024. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • AllianceBernstein held 75,250 shares of Cullinan Oncology worth $1.07M as of Q2 2026.
  • AllianceBernstein bought 27,620 Cullinan Oncology shares in Q2 2026, an estimated $410K.
  • Cullinan Oncology made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2356 holding.
  • AllianceBernstein first reported a position in Cullinan Oncology in Q2 2021 and has held it in 21 quarters since.
  • AllianceBernstein's Cullinan Oncology position peaked at $31M in Q3 2024.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.